Active Pharmaceutical Ingredients

The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products


Ardena buys a leading contract manufacturer of APIs

Contract development and manufacturing organisation (CDMO) Ardena, headquartered in Belgium, has acquired ChemConnection, a leading contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines.

Polypeptide Therapeutic Solutions and PMC Isochem start a joint activities

Polypeptide Therapeutic Solutions and PMC Isochem (both headquartered in France) signed a business and technology collaboration agreement in the field of cosmetic and therapeutic polypeptide.

Pfizer CentreOne launches its Enviero progesterone

Enviero progesterone is produced by a first-of-its-kind progesterone synthesis developed by Pfizer that reduces waste, greenhouse gas emissions and use of hazardous solvents.
medicinal cannabis

AXIM Biotech uses cGMP methods for its production of cannabinoid APIs

AXIM Biotechnologies announced the successful execution of proprietary cGMP methods to extract and microencapsulate cannabinoid molecules for a variety of pharmaceutical delivery formats from cGMP-produced medicinal cannabis.

Lonza boosts manufacturing capabilities in USA

Lonza, a Swiss chemicals and biotechnology, company announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in USA.

CARBOGEN AMCIS manufacturing facility passed a quality inspection

Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient manufacturing company, announced that its Vionnaz site has successfully completed a Swissmedic inspection


Expert opinion